Completed

N/A

192

Europe

Regorafenib 40 MG Oral Tablet [STIVARGA]

Istituto Oncologico Veneto IRCCS

Glioblastoma Multiforme

12/23

12/23

Recruiting

3

170

Europe

XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght, XyloCore 0.7 or 1.5 or 2.0, 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution, Physioneal 40 or 35, Fixioneal 40 or 35, Dianeal, Balance, Bicavera, Bicanova, Equibalance

Iperboreal Pharma Srl

End Stage Renal Disease

12/24

12/24